A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nab-paclitaxel.
Shetal A PatelBart SingerColette ShenAdam M ZanationWendell G YarbroughJared WeissPublished in: Clinical case reports (2021)
Unbiased transcriptomic sequencing may identify previously uncharacterized NUTM1 fusion partners. Gemcitabine and nab-paclitaxel is a well-tolerated combination chemotherapy regimen and could offer a novel treatment approach for NUT carcinoma.